tiprankstipranks
Iovance Biotherapeutics call volume above normal and directionally bullish
PremiumThe FlyIovance Biotherapeutics call volume above normal and directionally bullish
27d ago
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
PremiumPress Releases
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
1M ago
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
PremiumPress Releases
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
1M ago
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
PremiumPress ReleasesIovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
2M ago
Iovance Biotherapeutics options imply 12.1% move in share price post-earnings
PremiumThe Fly
Iovance Biotherapeutics options imply 12.1% move in share price post-earnings
2M ago
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
PremiumPress Releases
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
2M ago
Iovance Board Changes: McPeak Retires, Vogt Nominated
PremiumCompany AnnouncementsIovance Board Changes: McPeak Retires, Vogt Nominated
3M ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PremiumPress Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3M ago
Iovance Biotherapeutics price target raised to $19 from $18 at Piper Sandler
PremiumThe Fly
Iovance Biotherapeutics price target raised to $19 from $18 at Piper Sandler
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100